Abstract
Our understanding of the determinants of human life span and longevity has increased markedly during the last few decades. A number of environmental, lifestyle and genetic factors associated with longevity have been identified, and the intricate interplay between these components has been recognized. Various therapeutic approaches, especially those at the somatotropic and immunological axes, have been presented as means to reverse some of the impairments that accompany the aging process. Nevertheless, a considerable level of unexplained interindividual variation exists in the human life span, and despite promising results in animal models, many of the rejuvenation trials in humans have yet to be successful. This review discusses the genetic component of human longevity and its phenotypic effectors: the biomarkers and their target pathways. The focus is set on the somatotropic and immunological axes. In addition, a new longevity biomarker candidate, a circulating cell-free DNA (cf-DNA), is presented. cf-DNA is unique in that virtually any dying or senescent cell type can release it, making it a sensitive and compelling biomarker for aging research. Lastly, this review discusses several of the rejuvenation strategies proposed to augment senescent phenotypes. Because there is a growing interest in personalized treatment modalities and risk prediction scores in various age-related disorders, we highlight some of the genetic and age- and sex-specific factors that can modulate the response to such interventions.
Keywords: Aging, longevity, biomarker, inflammation, caloric restriction, cf-DNA.
Current Pharmaceutical Design
Title:Determinants of Longevity: Genetics, Biomarkers and Therapeutic Approaches
Volume: 20 Issue: 38
Author(s): Juulia Jylhava
Affiliation:
Keywords: Aging, longevity, biomarker, inflammation, caloric restriction, cf-DNA.
Abstract: Our understanding of the determinants of human life span and longevity has increased markedly during the last few decades. A number of environmental, lifestyle and genetic factors associated with longevity have been identified, and the intricate interplay between these components has been recognized. Various therapeutic approaches, especially those at the somatotropic and immunological axes, have been presented as means to reverse some of the impairments that accompany the aging process. Nevertheless, a considerable level of unexplained interindividual variation exists in the human life span, and despite promising results in animal models, many of the rejuvenation trials in humans have yet to be successful. This review discusses the genetic component of human longevity and its phenotypic effectors: the biomarkers and their target pathways. The focus is set on the somatotropic and immunological axes. In addition, a new longevity biomarker candidate, a circulating cell-free DNA (cf-DNA), is presented. cf-DNA is unique in that virtually any dying or senescent cell type can release it, making it a sensitive and compelling biomarker for aging research. Lastly, this review discusses several of the rejuvenation strategies proposed to augment senescent phenotypes. Because there is a growing interest in personalized treatment modalities and risk prediction scores in various age-related disorders, we highlight some of the genetic and age- and sex-specific factors that can modulate the response to such interventions.
Export Options
About this article
Cite this article as:
Jylhava Juulia, Determinants of Longevity: Genetics, Biomarkers and Therapeutic Approaches, Current Pharmaceutical Design 2014; 20 (38) . https://dx.doi.org/10.2174/1381612820666140314153818
DOI https://dx.doi.org/10.2174/1381612820666140314153818 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Angiotensin II and the Cardiac Complications of Diabetes Mellitus
Current Pharmaceutical Design Honey, Health and Longevity
Current Aging Science Atherosclerotic Renal Artery Stenosis: An Update on Diagnosis and Management
Current Vascular Pharmacology Effect of Androgenic and Antiandrogenic Acting Compounds in Macrophage Accumulation and Cell Replication in the Aorta of Oophorectomized Hypercholesterolemic Rabbits
Vascular Disease Prevention (Discontinued) A Role for Endothelin-1 in Peripheral Vascular Disease
Current Vascular Pharmacology Endothelial Dysfunction: The Link Between Homocysteine and Hydrogen Sulfide
Current Medicinal Chemistry Admission, 24 Hours and Discharge Troponin T Among Acute Myocardial Infarction Patients: Differing by Prognostic Contribution
Recent Patents on Biomarkers Central Arterial Aging and Angiotensin II Signaling
Current Hypertension Reviews Use of BNP and CRP as Biomarkers in Assessing Cardiovascular Disease:Diagnosis Versus Risk
Current Vascular Pharmacology Supplementation with Oligonol, Prevents Weight Gain and Improves Lipid Profile in Overweight and Obese Saudi Females
Current Nutrition & Food Science Heart Failure in South America
Current Cardiology Reviews Lipid Lowering Drugs and Gallstones: A Therapeutic Option?
Current Pharmaceutical Design Increased Fetal Cardiovascular Disease Risk: Potential Synergy Between Gestational Diabetes Mellitus and Maternal Hypercholesterolemia
Current Vascular Pharmacology Insulin Resistance and Endothelial Dysfunction: A Mutual Relationship in Cardiometabolic Risk
Current Pharmaceutical Design Vitamin D Metabolism and Potential Effects of Vitamin D Receptor Modulation in Chronic Kidney Disease
Current Drug Metabolism The Role of Diabetes in Molecular Pathogenesis of Cancer
Current Signal Transduction Therapy Peptide Metabolism and the Control of Body Fluid Homeostasis
Current Medicinal Chemistry - Cardiovascular & Hematological Agents High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease
Current Pharmaceutical Design Zinc and Cell Signaling During Inflammation: Implications in Atherosclerosis
Current Nutrition & Food Science Past, Present and Future of Electroanalytical Sensor for Aspirin, Ibuprofen and Paracetamol Detection
Current Pharmaceutical Analysis